Restrict Diclofenac package to save vultures: Ministry

Image
IANS New Delhi
Last Updated : Sep 18 2015 | 4:32 PM IST

The environment ministry has called for restricting the use of painkiller drug Diclofenac to a "single dose" package for humans to avoid its misuse for veterinary purposes and thereby cause a steep decline in the vulture population, an official statement said on Friday.

"Keeping in view the severity of the situation and the need to conserve and protect vultures from extinction, the ministry of environment, forest and climate change has requested the ministry of health and family welfare to restrict the pack of Diclofenac for human use to single dose only," the environment ministry said.

In 2006, it was banned for veterinary use as the drug, which was used to treat inflammation in livestock, was fatal for vultures with kidney and liver failure when they ate carcasses of animals treated with the drug.

"Even after banning the use of Diclofenac for veterinary use, the multi-dose vials available in the market for human use were widely misused for veterinary purpose. This, in turn, has a severe impact on the population of vultures," the statement said.

The commonly used anti-inflammatory drug for cattle was considered the "chief reason" for the steep decline in the number of vultures in recent years, it added.

--Indo-Asian News service

mp/tsb/bg

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 18 2015 | 4:20 PM IST

Next Story